{"organizations": [], "uuid": "d8011ec7afc94d04f294364f2a111257b5c23b3b", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 4, "shares": 4, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "uk.reuters.com", "main_image": "https://s3.reutersmedia.net/resources/r/?m=02&d=20180403&t=2&i=1247631777&w=1200&r=LYNXNPEE3212K", "site_section": "http://feeds.reuters.com/Reuters/UKBusinessNews?format=xml", "section_title": "Reuters: Business News", "url": "https://uk.reuters.com/article/uk-pfizer-divestiture-procter-gamble/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUKKCN1HA1UL", "country": "US", "domain_rank": 408, "title": "Pfizer in talks with P&G for consumer health unit sale - CNBC", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-03T18:04:00.000+03:00", "replies_count": 0, "uuid": "d8011ec7afc94d04f294364f2a111257b5c23b3b"}, "author": "", "url": "https://uk.reuters.com/article/uk-pfizer-divestiture-procter-gamble/pfizer-in-talks-with-pg-for-consumer-health-unit-sale-cnbc-idUKKCN1HA1UL", "ord_in_thread": 0, "title": "Pfizer in talks with P&G for consumer health unit sale - CNBC", "locations": [], "entities": {"persons": [{"name": "manas mishra", "sentiment": "none"}, {"name": "reckitt benckiser", "sentiment": "none"}, {"name": "sriraj kalluvila", "sentiment": "none"}], "locations": [{"name": "new york", "sentiment": "none"}, {"name": "u.s.", "sentiment": "none"}, {"name": "bengaluru", "sentiment": "none"}], "organizations": [{"name": "p&g", "sentiment": "negative"}, {"name": "cnbc", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "negative"}, {"name": "new york stock exchange", "sentiment": "none"}, {"name": "cnbc reuters staff", "sentiment": "none"}, {"name": "procter & gamble co p&g", "sentiment": "none"}, {"name": "glaxosmithkline", "sentiment": "none"}, {"name": "johnson & johnson", "sentiment": "none"}, {"name": "pfizer inc", "sentiment": "none"}, {"name": "jackson  pfizer", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 3, 2018 / 2:51 PM / Updated 44 minutes ago Pfizer in talks with P&G for consumer health unit sale - CNBC Reuters Staff 1 Min Read \n(Reuters) - Pfizer Inc ( PFE.N ) is in talks with Procter & Gamble Co ( PG.N ) for a sale of the largest U.S. drugmakerâ€™s consumer health business, CNBC reported on Tuesday, citing sources. A logo of Pfizer is displayed on a monitor outside of the New York Stock Exchange shortly after the opening bell in New York, U.S., December 5, 2017. REUTERS/Lucas Jackson \nThe companies were far apart on a price for the business and Pfizer is considering other options, including a joint venture with other drugmakers, the report said. \nPfizer said it is evaluating potential strategic options for the unit and expects to make a decision in 2018. \nGlaxoSmithKline ( GSK.L ), Reckitt Benckiser ( RB.L ) and Johnson & Johnson ( JNJ.N ) have all exited from the bidding process, endangering an auction Pfizer hoped would bring in as much as $20 billion \nP&G said it declined to comment. Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila", "external_links": [], "published": "2018-04-03T18:04:00.000+03:00", "crawled": "2018-04-03T18:23:01.001+03:00", "highlightTitle": ""}